Zymeworks at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Zymeworks brings 2 presentations to ENA 2026 in Barcelona. Its program centres on antibody-drug conjugates. It looks at antibody-targeted therapy conjugates as next-generation modalities in precision oncology.

OrganizationENA 2026 Attendance
Zymeworks
Vancouver, Canada
zymeworks.com
Biotech
Develops bispecific antibodies and antibody-drug conjugates; created zanidatamab for HER2-expressing cancers.
Session
Thu Nov 19
11:30am–1pm
Talk
Thu Nov 19
11:50am–12:10pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Zymeworks

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction